Innovaccer, which now has $41 million in capital, will use the funds to continue building on its suite of solutions and go-to-market capabilities. It plans on enhancing its InData platform’s machine-learning and interoperability capabilities. In addition, Innovaccer plans on building new patient engagement applications and platform capabilities for its partners.
The InData platform aggregates, normalizes and manages millions of patient records for 20-plus customers. Innovaccer also offers application modules, such as InCare and InGraph, to help clinicians improve patient outcomes.
Westbridge Capital led the series B funding round.
More articles on health IT:
Why Google renamed its research division ‘Google AI’
UCSF Health, UChicago Medicine partner with Color to offer patients genetic tests
‘Hundreds’ of diabetes apps haven’t proven successful health outcomes, HHS agency finds
